Literature DB >> 24445675

Urinary tract infections in patients with spinal injuries.

Lindsay E Nicolle1.   

Abstract

Urinary tract infection remains an important problem for patients with spinal cord injury. Interventions used to promote bladder emptying and maintain low-pressure voiding have variable risks for urinary tract infection. Asymptomatic bacteriuria is common in this population and should not be treated. However, identification of symptomatic infection is compromised by difficulties in ascertainment of symptoms. Use of hydrophilic coated catheters for intermittent catheterization does not influence the frequency of symptomatic urinary tract infection. Botulinum toxin injection in the detrusor muscle or the urethral sphincter improves bladder emptying and does not influence the frequency of urinary infection. Asymptomatic bacteriuria is a common finding in pregnant women with spinal cord injury, but optimal management is not clear. Other research needs include further development and evaluation of interventions to decrease the frequency of infection, improve diagnostic precision, and limit the emergence of resistant organisms.

Entities:  

Year:  2014        PMID: 24445675     DOI: 10.1007/s11908-013-0390-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  29 in total

Review 1.  Systematic review of urological followup after spinal cord injury.

Authors:  Anne P Cameron; Gianna M Rodriguez; Katherine G Schomer
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

2.  Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

Authors:  Sender Herschorn; Jerzy Gajewski; Karen Ethans; Jacques Corcos; Kevin Carlson; Gregory Bailly; Robert Bard; Luc Valiquette; Richard Baverstock; Lesley Carr; Sidney Radomski
Journal:  J Urol       Date:  2011-04-16       Impact factor: 7.450

Review 3.  Mission impossible? Urological management of patients with spinal cord injury during pregnancy: a systematic review.

Authors:  J Pannek; S Bertschy
Journal:  Spinal Cord       Date:  2011-06-14       Impact factor: 2.772

4.  An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity.

Authors:  Apostolos Apostolidis; Catherine Thompson; Xiaohong Yan; Sherif Mourad
Journal:  World J Urol       Date:  2012-11-18       Impact factor: 4.226

5.  Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.

Authors:  David Ginsberg; Angelo Gousse; Veronique Keppenne; Karl-Dietrich Sievert; Catherine Thompson; Wayne Lam; Mitchell F Brin; Brenda Jenkins; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2012-04-12       Impact factor: 7.450

6.  Urinary tract infections in patients with spinal cord injuries.

Authors:  Frederiek D'Hondt; Karel Everaert
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 7.  Pregnancy in women with physical disabilities.

Authors:  Caroline Signore; Catherine Y Spong; Danuta Krotoski; Nancy L Shinowara; Sean C Blackwell
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

Review 8.  Renal stone disease in spinal-cord-injured patients.

Authors:  Blayne Welk; Andrew Fuller; Hassan Razvi; John Denstedt
Journal:  J Endourol       Date:  2012-04-17       Impact factor: 2.942

9.  Influence of different urination methods on the urinary systems of patients with spinal cord injury.

Authors:  L Shen; X Zheng; C Zhang; B Zeng; C Hou
Journal:  J Int Med Res       Date:  2012       Impact factor: 1.671

10.  Results of urine culture and antimicrobial sensitivity tests according to the voiding method over 10 years in patients with spinal cord injury.

Authors:  Kyoung Ho Ryu; Yun Beom Kim; Seung Ok Yang; Jeong Kee Lee; Tae Young Jung
Journal:  Korean J Urol       Date:  2011-05-24
View more
  7 in total

Review 1.  UTIs in patients with neurogenic bladder.

Authors:  Mona S Jahromi; Amanda Mure; Christopher S Gomez
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

Review 2.  Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses.

Authors:  Carla Rognoni; Rosanna Tarricone
Journal:  BMJ Open       Date:  2017-01-17       Impact factor: 2.692

Review 3.  Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analyses.

Authors:  Carla Rognoni; Rosanna Tarricone
Journal:  BMC Urol       Date:  2017-01-10       Impact factor: 2.264

4.  A Proof-of-Concept Study of Transcutaneous Magnetic Spinal Cord Stimulation for Neurogenic Bladder.

Authors:  Tianyi Niu; Carol J Bennett; Tina L Keller; J C Leiter; Daniel C Lu
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.996

Review 5.  Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections.

Authors:  Michael Kennelly; Nikesh Thiruchelvam; Márcio Augusto Averbeck; Charalampos Konstatinidis; Emmanuel Chartier-Kastler; Pernille Trøjgaard; Rikke Vaabengaard; Andrei Krassioukov; Birte Petersen Jakobsen
Journal:  Adv Urol       Date:  2019-04-02

6.  Intermittent injection of Methylprednisolone Sodium Succinate in the treatment of Cervical Spinal Cord injury complicated with incomplete paraplegia.

Authors:  Wei Wang; Baoshu Zuo; Haixia Liu; Limin Cui
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

7.  Incidence of urinary tract infection following initiation of intermittent catheterization among patients with recent spinal cord injury in Germany and the Netherlands.

Authors:  Ariel Berger; Jimena Goldstine; Cheriel Hofstad; Gary W Inglese; Ruth Kirschner-Hermanns; Sharon MacLachlan; Surbhi Shah; Marije Vos-van der Hulst; Jerome Weiss
Journal:  J Spinal Cord Med       Date:  2020-10-15       Impact factor: 2.040

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.